Chromium picolinate attenuates hyperglycemia-induced oxidative stress in streptozotocin-induced diabetic rats

Journal of Trace Elements in Medicine and Biology

Volumn 27, Issue 2, 2013, Pages 117-121

  Sundaram, Bhuvaneshwari ^a   Aggarwal, Aanchal ^a   Sandhir, Rajat ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Antioxidants; Chromium picolinate; Hyperglycemia; Liver; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; CHROMIUM PICOLINATE; GLUTATHIONE; GLUTATHIONE REDUCTASE; LIVER ENZYME; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; HYPERGLYCEMIA; LIPID PEROXIDATION; LIVER; MALE; OXIDATIVE STRESS; PICOLINIC ACIDS; RATS; RATS, WISTAR; TRANSAMINASES;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84875103229     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.09.002     Document Type: Article

References (55)

1. Arrese M. Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus. Nat Rev Endocrinol 2010, 6:660-661.
2. Cheung N., Mitchell P., Wong T.Y. Diabetic retinopathy. Lancet 2010, 376:124-136.
3. Goldfine A.B., Fonseca V. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation 2010, 121:2447-2449.
4. Kotseva K., Wood D., De Backer G., De Bacquer D., Pyorala K., Reiner Z., et al. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil 2010, 17:530-540.
5. Kuyvenhoven J.P., Meinders A.E. Oxidative stress and diabetes mellitus: pathogenesis of long-term complications. Eur J Intern Med 1999, 10:9-19.
6. Kazi T.G., Afridi H.I., Kazi N., Jamali M.K., Arain M.B., Jalbani N., et al. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res 2008, 122:1-18.
7. Anderson R.A. Chromium in the prevention and control of diabetes. Diabetes Metab 2000, 26:22-27.
8. De Flora S. Threshold mechanisms and site specificity in chromium (VI) carcinogenesis. Carcinogenesis 2000, 21:533-541.
9. Sundaram B., Singhal K., Sandhir R. Ameliorating effect of chromium administration on hepatic glucose metabolism in streptozotocin-induced experimental diabetes. Biofactors 2012, 38:59-68.
10. Sundaram B., Singhal K., Sandhir R. Anti-atherogenic effect of chromium picolinate in streptozotocin-induced experimental diabetes. J Diabetes 2012, [Epub ahead of print]. 10.1111/j.1753-0407.2012.00211.x.
11. Jomova K., Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology 2011, 283:65-87.
12. Quievryn G., Peterson E., Messer J., Zhitkovich A. Genotoxicity and mutagenicity of chromium (VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry 2003, 42:1062-1070.
13. Tezuka M., Ishii S., Okada S. Chromium (III) decreases carbon tetrachloride-originated trichloromethyl radical in mice. J Inorg Biochem 1991, 44:261-265.
14. Ueno S., Susa N., Furukawa Y., Aikawa K., Itagaki I., Komiyama T., et al. Effect of chromium on lipid peroxidation in isolated rat hepatocytes. Nihon Juigaku Zasshi 1988, 50:45-52.
15. Shinde Urmila A., Sharma G., Xu Yan J., Dhalla Naranjan S., Goyal Ramesh K. Anti-diabetic activity and mechanism of action of chromium chloride. Exp Clin Endocrinol Diabetes 2004, 112:248-252.
16. Cefalu W.T., Hu F.B. Role of chromium in human health and in diabetes. Diabetes Care 2004, 27:2741-2751.
17. Jain S.K., Croad J.L., Velusamy T., Rains J.L., Bull R. Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol Nutr Food Res 2010, 54:1371-1380.
18. Stearns D.M. Mononuclear and binuclear chromium (III) picolinate complexes. Inorg Chem 1992, 31:6178-6184.
19. Anderson R.A., Cheng N., Bryden N.A., Polansky M.M., Chi J., Feng J. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 1997, 46:1786-1791.
20. Berner T.O., Murphy M.M., Slesinski R. Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement. Food Chem Toxicol 2004, 42:1029-1042.
21. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 1978, 52:302-310.
22. Beutler E., Yeh M.K. Erythrocyte glutathione reductase. Blood 1963, 21:573-585.
23. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 1978, 186:189-195.
24. Luck H. Catalase. Methods of enzymatic analysis 1971, Vol. 3:885-893. Academic Press, New York.
25. Horn H.D., Burns F.H. Assay of glutathione reductase activity. Methods of enzymatic analysis 1978, 142. Academic Press, New York. H.V. Bergmeyer (Ed.).
26. Martinek R.G. Method for the determination of vitamin E (total tocopherols) in serum. Clin Chem 1964, 10:1078-1086.
27. Roe J.H., Kuether C.A. The determination of ascorbic acid in whole blood and urine through the 2,4-dinitrophenylhydrazine derivative of dehydroascorbic acid. J Biol Chem 1943, 147:399-407.
28. Bradley D.W., Maynard J.E., Emery G., Webster H. Transaminase activities in serum of long-term hemodialysis patients. Clin Chem 1972, 18:1442.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
30. Anderson R.A. Chromium, glucose intolerance and diabetes. J Am Coll Nutr 1998, 17:548-555.
31. Stearns D.M. Is chromium a trace essential metal?. Biofactors 2000, 11:149-162.
32. Striffler J.S., Polansky M.M., Anderson R.A. Dietary chromium decreases insulin resistance in rats fed a high-fat, mineral-imbalanced diet. Metabolism 1998, 47:396-400.
33. Abdourahman A., Edwards J.G. Chromium supplementation improves glucose tolerance in diabetic Goto-Kakizaki rats. IUBMB Life 2008, 60:541-548.
34. Lamson D.W., Plaza S.M. The safety and efficacy of high-dose chromium. Altern Med Rev 2002, 7:218-235.
35. Hathcock J.N. Safety limits for nutrients. J Nutr 1996, 126:2386S-2389S.
36. Chen G., Liu P., Pattar G.R., Tackett L., Bhonagiri P., Strawbridge A.B., et al. Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 2006, 20:857-870.
37. Oberley L.W. Free radicals and diabetes. Free Radic Biol Med 1988, 5:113-124.
38. Opara E.C. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Promot Health 2002, 122:28-34.
39. Kesavulu M.M., Rao B.K., Giri R., Vijaya J., Subramanyam G., Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001, 53:33-39.
40. Davi G., Falco A., Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid Redox Signal 2005, 7:256-268.
41. Preuss H.G., Echard B., Perricone N.V., Bagchi D., Yasmin T., Stohs S.J. Comparing metabolic effects of six different commercial trivalent chromium compounds. J Inorg Biochem 2008, 102:1986-1990.
42. Anderson R.A., Roussel A.M., Zouari N., Mahjoub S., Matheau J.M., Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 2001, 20:212-218.
43. Bagchi D., Stohs S.J., Downs B.W., Bagchi M., Preuss H.G. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 2002, 180:5-22.
44. Jain S.K., Kahlon G., Morehead L., Dhawan R., Lieblong B., Stapleton T., et al. Effect of chromium dinicocysteinate supplementation on circulating levels of insulin, TNF-alpha, oxidative stress, and insulin resistance in type 2 diabetic subjects: randomized, double-blind, placebo-controlled study. Mol Nutr Food Res 2012, 56:1333-1341.
45. Paolisso G., Giugliano D. Oxidative stress and insulin action: is there a relationship?. Diabetologia 1996, 39:357-363.
46. Eklow L., Moldeus P., Orrenius S. Oxidation of glutathione during hydroperoxide metabolism. A study using isolated hepatocytes and the glutathione reductase inhibitor 1,3-bis(2-chloroethyl)-1-nitrosourea. Eur J Biochem 1984, 138:459-463.
47. Loven D., Schedl H., Wilson H., Daabees T.T., Stegink L.D., Diekus M., et al. Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin-induced diabetes. Diabetes 1986, 35:503-507.
48. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-kappaB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. J Nutr 2005, 135:2299-2304.
49. Kakkar R., Mantha S.V., Radhi J., Prasad K., Kalra J. Increased oxidative stress in rat liver and pancreas during progression of streptozotocin-induced diabetes. Clin Sci (Lond) 1998, 94:623-632.
50. Martin-Gallan P., Carrascosa A., Gussinye M., Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003, 34:1563-1574.
51. Refaie F.M., Esmat A.Y., Mohamed A.F., Aboul Nour W.H. Effect of chromium supplementation on the diabetes induced-oxidative stress in liver and brain of adult rats. Biometals 2009, 22:1075-1087.
52. Lai M.H. Antioxidant effects and insulin resistance improvement of chromium combined with vitamin C and e supplementation for type 2 diabetes mellitus. J Clin Biochem Nutr 2008, 43:191-198.
53. Maxwell S.R., Thomason H., Sandler D., Leguen C., Baxter M.A., Thorpe G.H., et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997, 27:484-490.
54. Salonen J.T., Nyyssonen K., Tuomainen T.P., Maenpaa P.H., Korpela H., Kaplan G.A., et al. Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ 1995, 311:1124-1127.
55. Machalinski B., Walczak M., Syrenicz A., Machalinska A., Grymula K., Stecewicz I., et al. Hypoglycemic potency of novel trivalent chromium in hyperglycemic insulin-deficient rats. J Trace Elem Med Biol 2006, 20:33-39.